Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
McKesson
Chubb
Mallinckrodt
McKinsey
Citi
Colorcon
Boehringer Ingelheim
Fuji

Generated: August 21, 2018

DrugPatentWatch Database Preview

LITHIUM CARBONATE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Lithium Carbonate patents expire, and when can generic versions of Lithium Carbonate launch?

Lithium Carbonate is a drug marketed by Able, Alembic Ltd, Apotex Inc, Glenmark Generics, Hetero Labs Ltd Iii, Mylan Pharms Inc, Usl Pharma, Watson Labs, West-ward Pharms Int, Alembic Pharms Ltd, Barr, Glenmark Pharms Inc, Heritage Pharma, Hikma Intl Pharms, Unique Pharm Labs, Pfizer, and Sun Pharm Inds Inc. and is included in twenty-nine NDAs.

The generic ingredient in LITHIUM CARBONATE is lithium carbonate. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.

Drug patent expirations by year for LITHIUM CARBONATE
Pharmacology for LITHIUM CARBONATE
Drug ClassMood Stabilizer
Medical Subject Heading (MeSH) Categories for LITHIUM CARBONATE
Synonyms for LITHIUM CARBONATE
10377-37-4 (mono-lithium salt)
12767-19-0
1312765-65-3
216964-61-3
2BMD2GNA4V
554-13-2
AC1L1WO8
AC1LANIP
AC1Q1U57
ACMC-209lmw
AKOS015904647
AN-45875
ANGC-554-13-2
ANW-32310
B7705
C07964
Camcolit
Candamide
Carbolite
Carbolith
Carbolithium
Carbolithium IFI
Carbolitium
Carbonic Acid Dilithium Salt
Carbonic acid lithium salt
Carbonic acid lithium salt (Li2CO3)
Carbonic acid, dilithium salt
Carbonic acid, lithium salt
Carbonic acid, lithium salt (1:2)
CCRIS 3153
Ceglution
CHEBI:6504
CHEMBL1200826
Cibalith-e
CLi2O3
CP 15467-61
CP-15,467-61
CP-15467-61
CP-1546761
CTK1G9703
D00801
D04UUH
Dilithium carbonate
Dilithium Carbonate, Dilithium Salt, Carbonic Acid
dilithium trioxidocarbonate
dilithium(1+) ion carbonate
diLithoTab CO3
Dilthium Carbonate
DTXSID1023784
Duralite
EC 209-062-5
EINECS 209-062-5
Eskalite
Eskalith
Eskalith (TN)
Eskalith CR
Eutimin
FT-0627895
GK3300
HSDB 3351
Hypnorex
I14-16784
I494
IN000219
IN006073
KS-0000025D
KSC269O0H
L0224
Li2CO3
Limas
Liskonum
Litard
Lithane
Lithea
Lithicarb
Lithinate
Lithionate
Lithium carbonate (2:1)
Lithium carbonate (JP17/USP)
Lithium carbonate (Li2CO3)
Lithium carbonate [USAN:JAN]
Lithium carbonate [USAN:USP:JAN]
Lithium carbonate, 99% 500g
LITHIUM CARBONATE, ACS
Lithium carbonicum
Lithium Phasal
Lithium QD
Lithium, Reference Standard Solution
Lithiumcarbonat
Lithiumcarbonate
Lithizine
Litho-Carb
Lithobid
Lithobid (TN)
Lithobie
Lithonate
Lithotabs
Lithotabs Priadee
Liticar
LS-88061
LTBB002486
Manialith
Maniprex
MFCD00011084
Micalith
MolPort-003-927-648
Neurolepsin
NSC-16895
OR284070
Pfi-lithium
Pfl-Lithium
Phasal
Plenur
Priadel
Quilonorm
Quilonum retard
RL04084
RTR-019539
Teralithe
Teralithe [French]
TR-019539
TRA0065195
UNII-2BMD2GNA4V
XGZVUEUWXADBQD-UHFFFAOYSA-L
Zabuyelite

US Patents and Regulatory Information for LITHIUM CARBONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc LITHIUM CARBONATE lithium carbonate TABLET, EXTENDED RELEASE;ORAL 202219-001 Aug 8, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Pharms Inc LITHIUM CARBONATE lithium carbonate TABLET, EXTENDED RELEASE;ORAL 091544-001 Dec 27, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Unique Pharm Labs LITHIUM CARBONATE lithium carbonate TABLET, EXTENDED RELEASE;ORAL 204779-001 Jul 27, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Heritage Pharma LITHIUM CARBONATE lithium carbonate TABLET, EXTENDED RELEASE;ORAL 205532-001 Sep 29, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Able LITHIUM CARBONATE lithium carbonate CAPSULE;ORAL 076823-001 Jun 29, 2004 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Usl Pharma LITHIUM CARBONATE lithium carbonate CAPSULE;ORAL 072542-001 Feb 1, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
McKesson
Chubb
Mallinckrodt
McKinsey
Citi
Colorcon
Boehringer Ingelheim
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.